Movement Disorders (revue) - Curation (Ncbi)

Index « Mesh.i » - entrée « Dopamine Agonists »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dopamine Agents < Dopamine Agonists < Dopamine Antagonists  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 199.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000008 (1999) A. Schrag [Royaume-Uni] ; L. Schelosky ; U. Scholz ; Werner Poewe [Autriche]Reduction of Parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anticholinergic single-dose challenges.
000020 (1999) J L Montastruc [France] ; M. Ziegler ; O. Rascol ; M. MalbezinA randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease.
000052 (1999) M. Merello [Argentine] ; A J Lees ; J. Balej ; A. Cammarota ; R. LeiguardaGPi firing rate modification during beginning-of-dose motor deterioration following acute administration of apomorphine.
000097 (1999) J. Fine ; A E LangDose-induced penile erections in response to ropinirole therapy for Parkinson's disease.
000100 (1999) P J Bédard [Canada] ; P J Blanchet ; D. Lévesque ; J J Soghomonian ; R. Grondin ; M. Morissette ; M. Goulet ; F. Calon ; P. Falardeau ; B. Gomez-Mancilla ; J P Doucet ; G S Robertson ; T. DipaoloPathophysiology of L-dopa-induced dyskinesias.
000107 (1999) P. Damier [France] ; C. Jaillon ; I. Clavier ; I. Arnulf ; A M Bonnet ; B P Bejjani ; Yves Agid [France]Dyskinesias assessment in Phase II studies.
000114 (1999) J L Montastruc [France] ; O. Rascol ; J M SenardTreatment of Parkinson's disease should begin with a dopamine agonist.
000119 (1999) P. Barbanti [Italie] ; G. Fabbrini ; A. Ricci ; R. Cerbo ; E. Bronzetti ; B. Caronti ; C. Calderaro ; L. Felici ; F. Stocchi ; G. Meco ; F. Amenta ; G L LenziIncreased expression of dopamine receptors on lymphocytes in Parkinson's disease.
000148 (1999) N. Gálvez-Jiménez ; T. KhanRopinirole and restless legs syndrome.
000153 (1999) J E Ahlskog [États-Unis] ; R J Uitti ; M K O'Connor ; D M Maraganore ; J Y Matsumoto ; K F Stark ; M F Turk ; O L BurnettThe effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.
000190 (2000) C. Ramaker [Pays-Bas] ; W J Van De Beek ; M J Finken ; B J Van HiltenThe efficacy and safety of adjunct bromocriptine therapy for levodopa-induced motor complications: a systematic review.
000209 (2000) S A Factor [États-Unis] ; D L Brown ; E S MolhoSubcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease.
000248 (2000) S A FactorThe initial treatment of Parkinson's disease.
000249 (2000) J L MontastrucTreatment of Parkinson's disease should begin with a dopamine agonist.
000302 (2000) L M Shulman [États-Unis] ; A. Minagar ; A. Rabinstein ; W J WeinerThe use of dopamine agonists in very elderly patients with Parkinson's disease.
000329 (2000) S A Treseder [Royaume-Uni] ; L A Smith ; P. JennerEndogenous dopaminergic tone and dopamine agonist action.
000373 (2000) S H Fox [Royaume-Uni] ; J M Brotchie5-HT2C receptor binding is increased in the substantia nigra pars reticulata in Parkinson's disease.
000447 (2001) G. Tissingh [Pays-Bas] ; H W Berendse ; P. Bergmans ; R. Dewaard ; B. Drukarch ; J C Stoof ; E C WoltersLoss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis.
000460 (2001) A. Albanese [Italie] ; U. Bonuccelli ; C. Brefel ; K R Chaudhuri ; C. Colosimo ; T. Eichhorn ; E. Melamed ; P. Pollak ; T. Van Laar ; M. ZappiaConsensus statement on the role of acute dopaminergic challenge in Parkinson's disease.
000467 (2001) Z. Vanek [États-Unis] ; Joseph Jankovic [États-Unis]Dystonia in corticobasal degeneration.
000475 (2001) F. Stocchi [Italie] ; L. Vacca ; A. Berardelli ; F. De Pandis ; S. RuggieriLong-duration effect and the postsynaptic compartment: study using a dopamine agonist with a short half-life.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "Dopamine Agonists" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i  \
                -Sk "Dopamine Agonists" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Dopamine Agonists
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024